Curanex Pharmaceuticals Inc (CURX)
NASDAQ: CURX · Real-Time Price · USD
7.92
+0.47 (6.31%)
At close: Sep 9, 2025, 4:00 PM
7.77
-0.15 (-1.89%)
After-hours: Sep 9, 2025, 7:58 PM EDT
Curanex Pharmaceuticals Statistics
Total Valuation
CURX has a market cap or net worth of $219.78 million. The enterprise value is $220.15 million.
Market Cap | 219.78M |
Enterprise Value | 220.15M |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
CURX has 27.75 million shares outstanding. The number of shares has increased by 3,084.84% in one year.
Current Share Class | 27.75M |
Shares Outstanding | 27.75M |
Shares Change (YoY) | +3,084.84% |
Shares Change (QoQ) | -0.33% |
Owned by Insiders (%) | 69.26% |
Owned by Institutions (%) | n/a |
Float | 8.53M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 719.57 |
P/TBV Ratio | 719.81 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.37, with a Debt / Equity ratio of 1.56.
Current Ratio | 9.37 |
Quick Ratio | 1.43 |
Debt / Equity | 1.56 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -81.20 |
Financial Efficiency
Return on equity (ROE) is -85.25% and return on invested capital (ROIC) is -30.15%.
Return on Equity (ROE) | -85.25% |
Return on Assets (ROA) | -30.03% |
Return on Invested Capital (ROIC) | -30.15% |
Return on Capital Employed (ROCE) | -50.77% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | n/a |
Average Volume (20 Days) | 2,911,098 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -361,095 |
Pretax Income | n/a |
Net Income | -435,034 |
EBITDA | n/a |
EBIT | -361,095 |
Earnings Per Share (EPS) | -$0.02 |
Balance Sheet
The company has $108,862 in cash and $476,452 in debt, giving a net cash position of -$367,590 or -$0.01 per share.
Cash & Cash Equivalents | 108,862 |
Total Debt | 476,452 |
Net Cash | -367,590 |
Net Cash Per Share | -$0.01 |
Equity (Book Value) | 305,431 |
Book Value Per Share | 0.01 |
Working Capital | 635,410 |
Cash Flow
Operating Cash Flow | -665,399 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CURX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -3,084.84% |
Shareholder Yield | -3,084.84% |
Earnings Yield | -0.20% |
FCF Yield | n/a |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |